Thymopoietin II: 32-34

Suppliers

Names

[ CAS No. ]:
85465-82-3

[ Name ]:
Thymopoietin II: 32-34

[Synonym ]:
Rgh 0205
Thymotrinanum [INN-Latin]
Arg-Lys-Asp
Thymotrinanum
N-(N(sup 2)-L-Arginyl-L-lysyl)-L-aspartic acid
Timotrinan
Timotrinan [INN-Spanish]
L-Aspartic acid,N-(N(sup 2)-L-arginyl-L-lysyl)
Thymotrinan
Thymopoietin II: 32-34

Chemical & Physical Properties

[ Density]:
1.51g/cm3

[ Molecular Formula ]:
C16H31N7O6

[ Molecular Weight ]:
417.46100

[ Exact Mass ]:
417.23400

[ PSA ]:
246.74000

[ LogP ]:
0.60820

[ Index of Refraction ]:
1.633

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
CI9099033
CHEMICAL NAME :
L-Aspartic acid, N-(N(sup 2)-L-arginyl-L-lysyl)-
CAS REGISTRY NUMBER :
85465-82-3
LAST UPDATED :
199407
DATA ITEMS CITED :
3
MOLECULAR FORMULA :
C16-H31-N7-O6
MOLECULAR WEIGHT :
417.54

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD - Lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
>1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 11,764,1986
TYPE OF TEST :
LD - Lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 11,764,1986
TYPE OF TEST :
LD - Lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
>1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 11,764,1986

Related Compounds

  • Thymopoietin II: 32-35
  • 6,14,16,24,32,34-Hexahydroxy-4,8,12,22,26,30-nonatriacontanehexone
  • (6R,14R,22R,30R,32S,34S)-6,14,22,30,32,34-Hexahydroxy-8,16,24-pentatriacontanetrione
  • Cyclostelletamines B
  • 36-bromo-3,6,9,12,15,18,21,24,27,30-decaoxabicyclo[30.3.1]hexatriaconta-1(36),32,34-triene
  • Thymopoietin II (32-36)-ethyl ester
  • 1-[4-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-1-methyl-1H-pyrazole-5-carbonyl]-3-hydroxyazetidine-3-carboxylic acid
  • 1-[5-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-1-methyl-1H-pyrazole-4-carbonyl]-3-hydroxyazetidine-3-carboxylic acid
  • 5-{[5-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-1-methyl-1H-pyrazol-3-yl]formamido}-4-methylpentanoic acid
  • 2-{[5-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-1-methyl-1H-pyrazol-4-yl]formamido}pent-4-enoic acid
  • 2-{1-[3-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-1-methyl-1H-pyrazol-5-yl]-N-(2-hydroxyethyl)formamido}acetic acid
  • 2-{1-[4-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-1-methyl-1H-pyrazole-5-carbonyl]azetidin-3-yl}acetic acid
  • 1-benzyl-3-[3-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-1-methyl-1H-pyrazole-5-amido]pyrrolidine-3-carboxylic acid
  • 4-{[5-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-1-methyl-1H-pyrazol-4-yl]formamido}-3-methoxybutanoic acid
  • 5-{1-[3-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-1-methyl-1H-pyrazol-5-yl]-N-methylformamido}pentanoic acid
  • 4-[3-cyclopropyl-3-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)propanamido]-1-methyl-1H-pyrazole-3-carboxylic acid
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.